Sobre a EDCTP

We are in the process of launching our new website. Please come back later to check it out.

A Parceria entre a Europa e os Países em Desenvolvimento para a Realização de Ensaios Clínicos (EDCTP) tem por objectivo acelerar o desenvolvimento de fármacos, vacinas, microbicidas e diagnósticos novos ou melhorados para o VIH/SIDA, a tuberculose e a malária, com particular incidência em ensaios clínicos da fase II e III na África subsaariana.

Portuguese title

Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.

Leia mais

Portuguese title

Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.

Leia mais

Portuguese title

Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.

Leia mais

Latest news

15 November 2018

PredART trial shows TB-IRIS can be prevented in patients with HIV-TB co-infection

The results of the PredART clinical trial co-funded by EDCTP were published in the New England Journal of Medicine on 14 November 2018. Prof. Graeme Meintjes (University of Cape Town) and his team showed that a moderate dose of prednisone…

Read more
1 November 2018

EDCTP and Wellcome Trust organise session at ASTMH 2018

EDCTP and the Wellcome Trust organised a session on controlled Human Infection Studies in low- and middle-income countries as a contribution to the ASTMH 2018 programme. The symposium (session 169) takes place on 1 November from 08:00-09:45. The annual meeting…

Read more